Cargando…

The Effect of a Single Freeze–Thaw Cycle on Matrix Metalloproteinases in Different Human Platelet-Rich Plasma Formulations

Storing platelet-rich plasma (PRP) for future use is a compelling approach, presuming the retention of biological properties is maintained. However, certain factors in PRP preparations have deleterious effects for the treatment of certain musculoskeletal conditions. The purpose of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitney, Kaitlyn E., Dornan, Grant J., King, Jillian, Chahla, Jorge, Evans, Thos A., Philippon, Marc J., LaPrade, Robert F., Huard, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533272/
https://www.ncbi.nlm.nih.gov/pubmed/34680520
http://dx.doi.org/10.3390/biomedicines9101403
_version_ 1784587272765571072
author Whitney, Kaitlyn E.
Dornan, Grant J.
King, Jillian
Chahla, Jorge
Evans, Thos A.
Philippon, Marc J.
LaPrade, Robert F.
Huard, Johnny
author_facet Whitney, Kaitlyn E.
Dornan, Grant J.
King, Jillian
Chahla, Jorge
Evans, Thos A.
Philippon, Marc J.
LaPrade, Robert F.
Huard, Johnny
author_sort Whitney, Kaitlyn E.
collection PubMed
description Storing platelet-rich plasma (PRP) for future use is a compelling approach, presuming the retention of biological properties is maintained. However, certain factors in PRP preparations have deleterious effects for the treatment of certain musculoskeletal conditions. The purpose of this study was to measure and compare matrix metalloproteinase protein (MMP) concentrations between fresh and freeze-thawed leukocyte-rich PRP (LR-PRP) inactivated (LR-I) and activated (LR-A) preparations, and leukocyte-poor PRP (LP-PRP) inactivated (LP-I) and activated (LP-A) preparations. A volume of 60 mL of whole blood was drawn from 19 healthy donors. LP-I and LR-I samples were processed using a manual extraction and centrifugation methodology. LP-A and LR-A products were activated with 10% CaCl(2) and recombinant thrombin. Blood fractions were either immediately assayed and analyzed or stored at −80 °C for 24, 72 and 160 h. Multiplex immunoassay was used to measure MMP-1, MMP-2, MMP-3, MMP-9, MMP-10, and MMP-12. MMP-1 concentrations increased in LR-A (p < 0.05) and MMP-9 significantly increased in LR-I (p < 0.05), while MMP-2 significantly decreased in LR-I (p < 0.05) and MMP-3 concentrations significantly decreased in LR-A (p < 0.05). MMP-12 concentrations also significantly decreased in LR-I (p < 0.05) from baseline concentrations. There were no significant differences between LP-A and LP-I preparations and MMP concentrations. MMP-10 concentrations in all PRP samples compared to each freezing time point were also not significantly different. MMPs regulate components of the extracellular matrix (ECM) in the remodeling phase of musculoskeletal injury. In this study, we observed a significant increase and decrease in MMP concentrations in response to a single freeze–thaw cycle in inactivated PRP and activated PRP preparations. This evidence contributes to the growing body of literature on the optimization of PRP preparation and storage strategies prior to delivery. Our findings suggest that specific PRP preparations after a single freeze–thaw may be more advantageous for certain musculoskeletal applications based on the presence of MMP concentrations.
format Online
Article
Text
id pubmed-8533272
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85332722021-10-23 The Effect of a Single Freeze–Thaw Cycle on Matrix Metalloproteinases in Different Human Platelet-Rich Plasma Formulations Whitney, Kaitlyn E. Dornan, Grant J. King, Jillian Chahla, Jorge Evans, Thos A. Philippon, Marc J. LaPrade, Robert F. Huard, Johnny Biomedicines Article Storing platelet-rich plasma (PRP) for future use is a compelling approach, presuming the retention of biological properties is maintained. However, certain factors in PRP preparations have deleterious effects for the treatment of certain musculoskeletal conditions. The purpose of this study was to measure and compare matrix metalloproteinase protein (MMP) concentrations between fresh and freeze-thawed leukocyte-rich PRP (LR-PRP) inactivated (LR-I) and activated (LR-A) preparations, and leukocyte-poor PRP (LP-PRP) inactivated (LP-I) and activated (LP-A) preparations. A volume of 60 mL of whole blood was drawn from 19 healthy donors. LP-I and LR-I samples were processed using a manual extraction and centrifugation methodology. LP-A and LR-A products were activated with 10% CaCl(2) and recombinant thrombin. Blood fractions were either immediately assayed and analyzed or stored at −80 °C for 24, 72 and 160 h. Multiplex immunoassay was used to measure MMP-1, MMP-2, MMP-3, MMP-9, MMP-10, and MMP-12. MMP-1 concentrations increased in LR-A (p < 0.05) and MMP-9 significantly increased in LR-I (p < 0.05), while MMP-2 significantly decreased in LR-I (p < 0.05) and MMP-3 concentrations significantly decreased in LR-A (p < 0.05). MMP-12 concentrations also significantly decreased in LR-I (p < 0.05) from baseline concentrations. There were no significant differences between LP-A and LP-I preparations and MMP concentrations. MMP-10 concentrations in all PRP samples compared to each freezing time point were also not significantly different. MMPs regulate components of the extracellular matrix (ECM) in the remodeling phase of musculoskeletal injury. In this study, we observed a significant increase and decrease in MMP concentrations in response to a single freeze–thaw cycle in inactivated PRP and activated PRP preparations. This evidence contributes to the growing body of literature on the optimization of PRP preparation and storage strategies prior to delivery. Our findings suggest that specific PRP preparations after a single freeze–thaw may be more advantageous for certain musculoskeletal applications based on the presence of MMP concentrations. MDPI 2021-10-06 /pmc/articles/PMC8533272/ /pubmed/34680520 http://dx.doi.org/10.3390/biomedicines9101403 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Whitney, Kaitlyn E.
Dornan, Grant J.
King, Jillian
Chahla, Jorge
Evans, Thos A.
Philippon, Marc J.
LaPrade, Robert F.
Huard, Johnny
The Effect of a Single Freeze–Thaw Cycle on Matrix Metalloproteinases in Different Human Platelet-Rich Plasma Formulations
title The Effect of a Single Freeze–Thaw Cycle on Matrix Metalloproteinases in Different Human Platelet-Rich Plasma Formulations
title_full The Effect of a Single Freeze–Thaw Cycle on Matrix Metalloproteinases in Different Human Platelet-Rich Plasma Formulations
title_fullStr The Effect of a Single Freeze–Thaw Cycle on Matrix Metalloproteinases in Different Human Platelet-Rich Plasma Formulations
title_full_unstemmed The Effect of a Single Freeze–Thaw Cycle on Matrix Metalloproteinases in Different Human Platelet-Rich Plasma Formulations
title_short The Effect of a Single Freeze–Thaw Cycle on Matrix Metalloproteinases in Different Human Platelet-Rich Plasma Formulations
title_sort effect of a single freeze–thaw cycle on matrix metalloproteinases in different human platelet-rich plasma formulations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533272/
https://www.ncbi.nlm.nih.gov/pubmed/34680520
http://dx.doi.org/10.3390/biomedicines9101403
work_keys_str_mv AT whitneykaitlyne theeffectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT dornangrantj theeffectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT kingjillian theeffectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT chahlajorge theeffectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT evansthosa theeffectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT philipponmarcj theeffectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT lapraderobertf theeffectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT huardjohnny theeffectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT whitneykaitlyne effectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT dornangrantj effectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT kingjillian effectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT chahlajorge effectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT evansthosa effectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT philipponmarcj effectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT lapraderobertf effectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations
AT huardjohnny effectofasinglefreezethawcycleonmatrixmetalloproteinasesindifferenthumanplateletrichplasmaformulations